Argeron Medical has developed a patented diagnostic kit specifically designed to measure biological aging rate — the speed at which biological damage accumulates over time.
The Argeron diagnostic kit is a standalone clinical tool. It generates actionable results without requiring artificial intelligence, while remaining compatible with optional AI-based decision support for extended interpretation.
The Argeron diagnostic kit measures biological aging rate, not chronological age and not a static biological age estimate.
Biological aging rate reflects:
This makes the measurement inherently longitudinal and predictive, rather than descriptive.
The kit is based on the quantitative measurement of protein deamidation kinetics, a spontaneous and chemically irreversible molecular process.
Why protein deamidation?
By quantifying deamidation kinetics, the kit captures a true aging-rate signal rather than transient biological noise.
The diagnostic kit is designed for use with standard LC-MS infrastructure, enabling high analytical precision and reproducibility.
Key characteristics:
The measurement result is generated locally by the laboratory or hospital, independent of cloud connectivity.
A critical design principle of the Argeron diagnostic kit is clinical independence.
Artificial intelligence is not part of the measurement step.
The assay chemistry, measurement methodology, and analytical framework underlying the diagnostic kit are protected by international patent filings.
This protection ensures:
While the diagnostic kit functions independently, users may optionally choose to upload their results to Argeron’s AI-based clinical decision support platform.
In this context, AI:
Clinical autonomy always remains with the local institution.
The Argeron diagnostic kit enables:
It shifts aging assessment from static estimation to dynamic measurement.
This is a diagnostic kit first — designed to quantify how fast biology changes, not just how old it is.